Dr. Reddy’s and UCB India agrees to co-promote and distribute Briviact for treatment of Epilepsy
MediaInfoline
Jul 09
Dr. Reddy’s Laboratories Limited and UCB, a biopharmaceutical company, announced that they have entered into a distribution and co-promotion agreement for Briviact®, a brand of brivaracetam. The agreement grants Dr. Reddy’s the exclusive right to ...
